Metalloproteinase ADAMTS-1 but not ADAMTS-5 is manifold overexpressed in neurodegenerative disorders as Down syndrome, Alzheimer's and Pick's disease

被引:35
|
作者
Miguel, RF [1 ]
Pollak, A [1 ]
Lubec, G [1 ]
机构
[1] Med Univ Vienna, Dept Pediat, CChem FRSC UK, A-1090 Vienna, Austria
来源
MOLECULAR BRAIN RESEARCH | 2005年 / 133卷 / 01期
关键词
metalloproteinase; ADAMTS; neurodegeneration; Down syndrome; Alzheimer's disease; Pick's disease;
D O I
10.1016/j.molbrainres.2004.09.008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
ADAMTS- 1 is a disintegrin and metalloproteinase with thrombospondin 1 (TSP 1)-like motifs with ubiquitous though variable expression. Natural substrates of this protease are proteoglycans as aggrecan and versican and null mutant mice propose a role for growth, fertility, organ structure and function. As the gene for this protein is encoded on chromosome 21 and maybe overexpressed due to the gene dosage hypothesis based upon the presence of a third chromosome in trisomy 2 1, we decided to study expression in Down syndrome (DS) brain and used brains of patients with Alzheimer's (AD) and Pick's disease (PD) as controls. Frontal cortex of controls, DS, AD and PD were homogenized and extracted proteins were used for immumoblotting using antibodies against ADAMTS-1 and ADA-MTS-5. ADAMTS-1-immunoreactivity was manifold increased in brain with DS and neurodegeneration, whereas ADAMTS-5 levels were comparable. Overexpression of this metalloproteinase maybe specifically involved in proteoglycan degradation and handling in brain of patients with neurodegenerative disease which in turn may lead to or reflect pathological lesions in DS, AD and PD brain. The manifold overexpression of ADAMTS-I may be used as marker protein for neurodegeneration. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [21] Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease
    Ryu, Young Shin
    Park, So Young
    Jung, Min-Su
    Yoon, Song-Hee
    Kwen, Mi-Yang
    Lee, Sun-Young
    Choi, Sun-Hee
    Radnaabazar, Chinzorig
    Kim, Mi-Kyoung
    Kim, Hangun
    Kim, Kwonseop
    Song, Woo-Joo
    Chung, Sul-Hee
    JOURNAL OF NEUROCHEMISTRY, 2010, 115 (03) : 574 - 584
  • [22] BRAIN INTERLEUKIN-1 AND S-100 IMMUNOREACTIVITY ARE ELEVATED IN DOWN SYNDROME AND ALZHEIMER-DISEASE
    GRIFFIN, WST
    STANLEY, LC
    LING, C
    WHITE, L
    MACLEOD, V
    PERROT, LJ
    WHITE, CL
    ARAOZ, C
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (19) : 7611 - 7615
  • [23] DYRK1a Inhibitor Mediated Rescue of Drosophila Models of Alzheimer's Disease-Down Syndrome Phenotypes
    Zhu, Bangfu
    Parsons, Tom
    Stensen, Wenche
    Mjoen Svendsen, John S.
    Fugelli, Anders
    Hodge, James J. L.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [24] DYRK1a Inhibitor Mediated Rescue of Drosophila Models of Alzheimer's Disease-Down Syndrome Phenotypes
    Zhu, Bangfu
    Parsons, Tom
    Stensen, Wenche
    Svendsen, John S. Mjoen
    Fugelli, Anders
    Hodge, James J. L.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [25] Ibuprofen and lipoic acid codrug 1 control Alzheimer's disease progression by down-regulating protein kinase C ε-mediated metalloproteinase 2 and 9 levels in β-amyloid infused Alzheimer's disease rat model
    Zara, S.
    Rapino, M.
    Sozio, P.
    Di Stefano, A.
    Nasuti, C.
    Cataldi, A.
    BRAIN RESEARCH, 2011, 1412 : 79 - 87
  • [26] Correlating hippocampal and amygdala volumes with neuropathological burden in Down syndrome and Alzheimer's disease and related neurodegenerative pathologies using 7T postmortem MRI
    Liou, Jr-Jiun
    Li, Jinghang
    Berardinelli, Jacob
    Jin, Hecheng
    Santini, Tales
    Noh, Jaehoon
    Farhat, Nadim
    Wu, Minjie
    Aizenstein, Howard J.
    Mettenburg, Joseph M.
    Yong, William H.
    Head, Elizabeth
    Ikonomovic, Milos D.
    Ibrahim, Tamer S.
    Kofler, Julia K.
    Alzheimer Biomarker Consortium Down Syndrome, Beau M.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2025,
  • [27] Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome
    Meijer, Laurent
    Chretien, Emilie
    Ravel, Denis
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 : S95 - S113
  • [28] Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes
    Garcia-Cerro, Susana
    Rueda, Noerni
    Vidal, Veronica
    Lantigua, Sara
    Martinez-Cue, Carmen
    NEUROBIOLOGY OF DISEASE, 2017, 106 : 76 - 88
  • [29] High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome:: A 1H MRS study
    Huang, W
    Alexander, GE
    Daly, EM
    Shetty, HU
    Krasuski, JS
    Rapoport, SI
    Schapiro, MB
    AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (12): : 1879 - 1886
  • [30] Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome
    Lee, Joseph. H.
    Chulikavit, Maruit
    Pang, Deborah
    Zigman, Warren B.
    Silverman, Wayne
    Schupf, Nicole
    NEUROSCIENCE LETTERS, 2007, 425 (02) : 105 - 109